epiglucan and Eye-Diseases

epiglucan has been researched along with Eye-Diseases* in 2 studies

Other Studies

2 other study(ies) available for epiglucan and Eye-Diseases

ArticleYear
28-Day oral toxicity study in rats with high purity barley beta-glucan (Glucagel).
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2010, Volume: 48, Issue:1

    Beta-glucans are glucose polymers present in cereal grains, particularly barley and oat. Consumption of these grains or concentrated beta-glucan preparations has been shown to lower blood cholesterol. The present study was conducted to assess the safety of a high purity (>75%) barley beta-glucan (Glucagel). The product was fed to Wistar rats (5/sex/group) at dietary levels of 0% (control), 1%, 5% and 10% for 28 days. Clinical and neurobehavioural observations, growth, feed and water consumption, ophthalmoscopy, haematology, clinical chemistry, urinalysis, organ weights, necropsy and histopathological examination revealed no adverse effects of Glucagel. High-dose males exhibited lower plasma cholesterol and phospholipids levels and a higher plasma urea level. These slight changes were considered of no toxicological significance. Full and empty caecum weights were increased in mid- and high-dose males. This caecal enlargement was a physiological response to the consumption of a high amount of indigestible carbohydrate and considered of no toxicological concern. In conclusion, feeding Glucagel at dietary levels up to 10% for 28 days was tolerated without any signs of toxicity. This dietary level was equivalent to 7.7 g Glucagel (5.8 g beta-glucan)/kg body weight/day in male rats and 7.8 g Glucagel (5.9 g beta-glucan)/kg body weight/day in female rats.

    Topics: Administration, Oral; Animal Feed; Animals; Behavior, Animal; beta-Glucans; Blood Cell Count; Body Weight; Diet; Dose-Response Relationship, Drug; Eating; Eye Diseases; Female; Hordeum; Male; Organ Size; Rats; Rats, Wistar; Urinalysis

2010
Effects on human eyes caused by experimental exposures to office dust with and without addition of aldehydes or glucan.
    Indoor air, 2009, Volume: 19, Issue:1

    Thirty-six volunteers (in three susceptibility groups: 11 subjects were non-allergic with nasal histamine hypersensitivity, 13 were non-allergic with normal sensitivity, and 12 were pollen allergic with or without nasal hypersensitivity) were exposed for three and a half hours in a climate chamber. Each subject was exposed to clean air (dust 45 +/- 38 microg/m(3) total suspended particle, TSP), house dust at 357 +/- 180 microg/m(3) TSP, house dust 382 +/- 175 microg/m(3) TSP with added glucan (50 ng/m(3)) and house dust 394 +/- 168 microg/m(3) TSP with added aldehydes corresponding to a gaseous phase of 300 microg/m(3) in the air. The study was explorative by nature. No significant effects of exposures as such were seen on break-up time, conjunctival epithelial damage score and Trolox Equivalent Antioxidant Capacity (TEAC) in tear film and subjective ratings. However, in TEAC a significant different time course was seen during exposures to aldehyde-containing dust indicating a subacute and late response to the exposures. Perceived eye irritation increased significantly during exposures to normal dust. The perception ratings were highly correlated, whereas no correlation was found between the subjective responses and the objective measurements.. The findings indicate that measurement effects on the eyes are rather insensitive measures of short time effects of office dust exposures.

    Topics: Air Pollutants, Occupational; Aldehydes; beta-Glucans; Dust; Eye Diseases; Humans; Hypersensitivity; Proteoglycans

2009